Even with access to blockbuster obesity drugs, some people don't lose weight
In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...
Monthly Prescribing Reference21h
Glucagon-Like Peptide-1 Receptor Agonists May Reduce Alcohol Consumption
(HealthDay News) — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use may reduce alcohol consumption and improve outcomes in some individuals, according to a study published online Nov. 14 in ...